Gene Page:LBP
概括?
基因 | 3929 |
象征 | LBP |
Synonyms | BPIFD2 |
Description | lipopolysaccharide binding protein |
Reference | MIM:151990|HGNC:HGNC:6517|Ensembl:ENSG00000129988|HPRD:07175|Vega:OTTHUMG00000032447 |
Gene type | protein-coding |
Map location | 20q11.23 |
Pascal p-value | 0.826 |
数据源中的基因
Gene set name | Method of gene set | Description | Info |
---|---|---|---|
CV:PGCnp | Genome-wide Association Study | GWAS | |
PMID:cooccur | High-throughput literature-search | Systematic search in PubMed for genes co-occurring with SCZ keywords. A total of 3027 genes were included. | |
Literature | High-throughput literature-search | Co-occurance with Schizophrenia keywords: schizophrenia,schizophrenias | 点击to show details |
GO_Annotation | Mapping neuro-related keywords to Gene Ontology annotations | 与神经相关的关键字的命中:1 |
第一节遗传学和表观遗传学注释
Section II. Transcriptome annotation
General gene expression (GTEx)
![Not available](http://www.tjghsg.com/bioinfo/SZGR/GeneImg/LBP_DE_GTEx.png)
Gene expression of temporal and spatial changes (BrainSpan)
脚注:
SC: sub-cortical regions; SM: sensory-motor regions; FC: frontal cortex; and TP: temporal-parietal cortex
ST1: fetal (13 - 26 postconception weeks), ST2: early infancy to late childhood (4 months to 11 years), and ST3: adolescence to adulthood (13 - 23 years)
The bar shown representes the lower 25% and upper 25% of the expression distribution.
Top co-expressed genes in brain regions
Top 10 positively co-expressed genes | ||
Gene | Pearson's Correlation | Spearman's Correlation |
TGFBRAP1 | 0.95 | 0.95 |
AC097382.4 | 0.94 | 0.94 |
DHX37 | 0.94 | 0.95 |
SREBF2 | 0.94 | 0.95 |
Neurl4 | 0.93 | 0.95 |
CLIP2 | 0.93 | 0.94 |
DIP2C | 0.93 | 0.94 |
FOXK2 | 0.93 | 0.95 |
KIAA1967 | 0.93 | 0.94 |
BICD2 | 0.93 | 0.93 |
Top 10 negatively co-expressed genes | ||
Gene | Pearson's Correlation | Spearman's Correlation |
AF347015.31 | -0.79 | -0.86 |
MT-CO2 | -0.77 | -0.86 |
AF347015.27 | -0.76 | -0.84 |
AF347015.21 | -0.75 | -0.91 |
AF347015.33 | -0.74 | -0.81 |
AC021016.1 | -0.74 | -0.82 |
FXYD1 | -0.73 | -0.80 |
AF347015.8 | -0.73 | -0.84 |
MT-CYB | -0.73 | -0.81 |
HIGD1B | -0.73 | -0.82 |
Section III. Gene Ontology annotation
Molecular function | GO term | Evidence | Neuro keywords | PubMed ID |
---|---|---|---|---|
GO:0005102 | receptor binding | ISS | Neurotransmitter (GO term level: 4) | 2477488 |
GO:0001530 | lipopolysaccharide binding | IEA | - | |
GO:0008289 | lipid binding | IEA | - | |
GO:0043498 | cell surface binding | ISS | 2477488 | |
GO:0051636 | Gram-negative bacterial cell surface binding | IDA | 11528597 | |
GO:0051636 | Gram-negative bacterial cell surface binding | ISS | 2402637 | |
GO:0051637 | 革兰氏阳性细菌细胞表面结合 | IDA | 12932360 | |
生物过程 | GO term | Evidence | Neuro keywords | PubMed ID |
GO:0002281 | macrophage activation during immune response | ISS | 2402637 | |
GO:0034145 | positive regulation of toll-like receptor 4 signaling pathway | IDA | 11528597 | |
GO:0006968 | cellular defense response | ISS | 2402637 | |
GO:0006953 | acute-phase response | IEP | 12932360 | |
GO:0006953 | acute-phase response | ISS | 2477488 | |
GO:0006869 | lipid transport | IEA | - | |
GO:0008228 | opsonization | IC | 12932360 | |
GO:0008228 | opsonization | ISS | 2477488 | |
GO:0015920 | lipopolysaccharide transport | IDA | 8985160 | |
GO:0032757 | positive regulation of interleukin-8 production | IDA | 8409400 | |
GO:0032496 | 对脂多糖的反应 | IDA | 8409400|11739189 | |
GO:0032490 | detection of molecule of bacterial origin | IDA | 11528597 | |
GO:0032760 | positive regulation of tumor necrosis factor production | IDA | 8409400 | |
GO:0032760 | positive regulation of tumor necrosis factor production | ISS | 2402637 | |
GO:0032755 | positive regulation of interleukin-6 production | IDA | 8409400 | |
GO:0032720 | negative regulation of tumor necrosis factor production | IDA | 11739189 | |
GO:0031663 | lipopolysaccharide-mediated signaling pathway | IDA | 8409400|11739189 | |
GO:0043032 | positive regulation of macrophage activation | IDA | 8409400 | |
GO:0050830 | defense response to Gram-positive bacterium | IC | 12932360 | |
GO:0050830 | defense response to Gram-positive bacterium | IEP | 12932360 | |
GO:0050829 | defense response to Gram-negative bacterium | ISS | 2402637 | |
GO:0045087 | 先天免疫反应 | IC | 12932360 | |
GO:0045087 | 先天免疫反应 | ISS | 2477488 | |
GO:0060265 | positive regulation of respiratory burst during acute inflammatory response | ISS | - | |
Cellular component | GO term | Evidence | Neuro keywords | PubMed ID |
GO:0005576 | extracellular region | 经验 | 2477488|9665271 | |
GO:0005576 | extracellular region | IEA | - | |
GO:0005615 | extracellular space | IDA | 2402637|11528597 | |
GO:0005615 | extracellular space | ISS | 2477488 | |
GO:0005634 | nucleus | IDA | 18029348 |
V.途径注释
Pathway name | Pathway size | # SZGR 2.0 genes in pathway | Info |
---|---|---|---|
KEGG TOLL LIKE RECEPTOR SIGNALING PATHWAY | 102 | 88 | 该途径中的所有SZGR 2.0基因 |
BIOCARTA GSK3 PATHWAY | 27 | 26 | 该途径中的所有SZGR 2.0基因 |
PID IL6 7 PATHWAY | 47 | 40 | 该途径中的所有SZGR 2.0基因 |
REACTOME INNATE IMMUNE SYSTEM | 279 | 178 | 该途径中的所有SZGR 2.0基因 |
REACTOME IMMUNE SYSTEM | 933 | 616 | 该途径中的所有SZGR 2.0基因 |
REACTOME TOLL RECEPTOR CASCADES | 118 | 84 | 该途径中的所有SZGR 2.0基因 |
CASTELLANO NRAS TARGETS UP | 68 | 41 | 该途径中的所有SZGR 2.0基因 |
FARMER BREAST CANCER APOCRINE VS LUMINAL | 326 | 213 | 该途径中的所有SZGR 2.0基因 |
DAUER STAT3 TARGETS UP | 49 | 35 | 该途径中的所有SZGR 2.0基因 |
Schaeffer前列腺开发48小时DN | 428 | 306 | 该途径中的所有SZGR 2.0基因 |
GOTZMANN EPITHELIAL TO MESENCHYMAL TRANSITION DN | 206 | 136 | 该途径中的所有SZGR 2.0基因 |
SHEN SMARCA2 TARGETS DN | 357 | 212 | 该途径中的所有SZGR 2.0基因 |
BYSTRYKH HEMATOPOIESIS STEM CELL QTL TRANS | 882 | 572 | 该途径中的所有SZGR 2.0基因 |
NADLER OBESITY UP | 61 | 34 | 该途径中的所有SZGR 2.0基因 |
阿布得生活信号1 | 46 | 29 | 该途径中的所有SZGR 2.0基因 |
IVANOVA HEMATOPOIESIS EARLY PROGENITOR | 532 | 309 | 该途径中的所有SZGR 2.0基因 |
URS ADIPOCYTE DIFFERENTIATION UP | 74 | 51 | 该途径中的所有SZGR 2.0基因 |
CUI TCF21 TARGETS UP | 37 | 27 | 该途径中的所有SZGR 2.0基因 |
MCLACHLAN DENTAL CARIES DN | 245 | 144 | 该途径中的所有SZGR 2.0基因 |
CUI TCF21 TARGETS 2 UP | 428 | 266 | 该途径中的所有SZGR 2.0基因 |
HAN JNK SINGALING DN | 39 | 27 | 该途径中的所有SZGR 2.0基因 |
MCLACHLAN DENTAL CARIES UP | 253 | 147 | 该途径中的所有SZGR 2.0基因 |
LEIN CHOROID PLEXUS MARKERS | 103 | 61 | 该途径中的所有SZGR 2.0基因 |
COATES MACROPHAGE M1 VS M2 DN | 78 | 44 | 该途径中的所有SZGR 2.0基因 |
MARTINEZ RB1 TARGETS DN | 543 | 317 | 该途径中的所有SZGR 2.0基因 |
MARTINEZ TP53 TARGETS UP | 602 | 364 | 该途径中的所有SZGR 2.0基因 |
MARTINEZ RB1 AND TP53 TARGETS UP | 601 | 369 | 该途径中的所有SZGR 2.0基因 |
乳腺癌萧述三腔L B DN | 564 | 326 | 该途径中的所有SZGR 2.0基因 |
SMID BREAST CANCER ERBB2 UP | 147 | 83 | 该途径中的所有SZGR 2.0基因 |
QI PLASMACYTOMA DN | 100 | 63 | 该途径中的所有SZGR 2.0基因 |
ICHIBA GRAFT VERSUS HOST DISEASE D7 UP | 107 | 67 | 该途径中的所有SZGR 2.0基因 |
Ichiba移植与宿主疾病35D UP | 131 | 79 | 该途径中的所有SZGR 2.0基因 |
SWEET LUNG CANCER KRAS UP | 491 | 316 | 该途径中的所有SZGR 2.0基因 |
COLINA TARGETS OF 4EBP1 AND 4EBP2 | 356 | 214 | 该途径中的所有SZGR 2.0基因 |
MIKKELSEN MCV6 LCP WITH H3K4ME3 | 162 | 80 | 该途径中的所有SZGR 2.0基因 |
CAIRO LIVER DEVELOPMENT DN | 222 | 141 | 该途径中的所有SZGR 2.0基因 |
KAMIKUBO MYELOID CEBPA NETWORK | 28 | 19 | 该途径中的所有SZGR 2.0基因 |
STAMBOLSKY TARGETS OF MUTATED TP53 DN | 50 | 24 | 该途径中的所有SZGR 2.0基因 |
CHYLA CBFA2T3 TARGETS UP | 387 | 225 | 该途径中的所有SZGR 2.0基因 |
PILON KLF1 TARGETS DN | 1972 | 1213 | 该途径中的所有SZGR 2.0基因 |
GOBERT OLIGODENDROCYTE DIFFERENTIATION DN | 1080 | 713 | 该途径中的所有SZGR 2.0基因 |
LIM MAMMARY LUMINAL PROGENITOR UP | 58 | 30 | 该途径中的所有SZGR 2.0基因 |
Section VI. microRNA annotation
miRNA family | Target position | miRNA ID | miRNA seq | ||
---|---|---|---|---|---|
UTR start | UTR end | Match method | |||
miR-500 | 162 | 168 | m8 | hsa-miR-500 | AUGCACCUGGGCAAGGAUUCUG |